Search
for
Sort by
Research 91–120 of 1000+
- Use of Myoinositol in PCOS
- Valproate Induced Hair Loss and Curly Hair in Bipolar Disorder
- Semaglutide as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights
- CHEMISTRY AND SIGNIFICANCE OF CHEMOPREVENTIVE NUTRACEUTICALS: A REVIEW
- 41495 Efficacy of Oral Naltrexone in the Treatment of Scarring Alopecia
- A 2018 Approach to Combating Methotrexate Toxicity Folic Acid and Beyond.
- Therapeutic Efficacy of Combination Therapy Using Oral Cyclosporine with a Dietary Supplement (Pantogar®) in Twenty-Nail Dystrophy
- The Evolution of Emerging Nanovesicle Technologies for Enhanced Delivery of Molecules into and across the Skin
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Combination Therapy with Cyclosporine and Psoralen Plus Ultraviolet A in the Patients with Severe Alopecia Areata: A Retrospective Study with a Self-Controlled Design
- Topiramate vs Divalproex Sodium in the Preventive Treatment of Migraine: A Prospective “Real‐World” Study
- Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels.
- Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
- Rapid hair depigmentation in patient treated with pazopanib
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- In Patients With Acne Vulgaris, How Do Standard Acne Treatments Combined With Adjunct Microbiome-Targeted Therapies Compare to Standard Acne Treatments Alone in Affecting Clinical Outcomes?
- Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review
- USE OF RITLECITINIB FOR THE TREATMENT OF ALOPECIA AREATA
- PWE-049 Assessment of response and tolerance to oral iron supplements in patients with anaemia
- An observational study of leflunomide in the treatment of lupus nephyritis for cyclophosphamide was invalid or could not be tolerated
- Drug Treatment of Acute Leukaemia Current Status
- Valproic acid (Depakene). A new anticonvulsant agent
- Tinea Capitis
- Tinea Capitis
- Chemical Gastroenterocolitis After the Root Canal Therapy - A Case Report
- Essential Oils and Melatonin as Functional Ingredients in Dogs
- Colchicine in Managing Skin Conditions: A Systematic Review
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy